Neue Aspekte in der Therapie von Schilddrüsenkarzinomen : Highlights des ASCO-Kongresses 2016 [New aspects in the treatment of thyroid cancer : Highlights of the ASCO Annual Meeting 2016]

Détails

ID Serval
serval:BIB_A1DCD7E76A67
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Compte-rendu: analyse d'une oeuvre publiée.
Collection
Publications
Institution
Titre
Neue Aspekte in der Therapie von Schilddrüsenkarzinomen : Highlights des ASCO-Kongresses 2016 [New aspects in the treatment of thyroid cancer : Highlights of the ASCO Annual Meeting 2016]
Périodique
HNO
Auteur(s)
Lörincz B.B., Simon C., Möckelmann N., Knecht R.
ISSN
1433-0458 (Electronic)
ISSN-L
0017-6192
Statut éditorial
Publié
Date de publication
10/2016
Peer-reviewed
Oui
Volume
64
Numéro
10
Pages
736-740
Langue
allemand
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Résumé
The annual meeting of the American Society of Clinical Oncology (ASCO) took place at the beginning of June 2016 in Chicago. This year a total of 28 studies on the treatment of patients with thyroid cancer were presented, described in this review article according to the degree of cancer cell differentiation. The leading curative treatment modality is still surgery. In contrast, kinase inhibitors are being used increasingly within palliative concepts. The latest state of the art of thyroid cancer treatment, both surgical and medical, is summarized in this review.

Pubmed
Création de la notice
23/09/2016 18:41
Dernière modification de la notice
20/08/2019 16:07
Données d'usage